Updated consumer resource explains eGFR and UACR testing, individualized nutrition, medication oversight and how to ...

Chronic kidney disease might sound alarming, but it doesn't always lead to kidney failure. With timely diagnosis and ...

Bayer just scored another label expansion for its blockbuster-in-waiting, Kerendia. | The heart and kidney med earned the first FDA nod in three decades for adults with chronic kidney disease ...

Diagnosis of women's chronic kidney disease (CKD) is often delayed, and they are less likely to begin dialysis or receive a kidney transplant. Several female-specific factors impact women's kidney and ...

A chronic kidney disease linked to physical labor in the heat is sickening largely undocumented workers in Texas, where ...

Women with CKD often receive a delayed diagnosis and are less likely to receive a kidney transplant. These trends mean, among other things, those women face an increased risk of developing heart ...

Heart disease and chronic kidney disease can accelerate one another, but new guidelines say simple screening and early ...

Your morning meal may not be as kidney-friendly as it seems.

A mysterious chronic kidney disease devastating Central America's agricultural workers appears to have surfaced among Texas ...

The FDA approved KERENDIA to reduce UACR, which is expected to slow chronic kidney disease progression in adults with CKD associated with T1D. 1 This approval is important for patients, as it is the ...

In a clinical guideline published online Sept. 15 in the Annals of Internal Medicine, updated recommendations are presented ...